Splash Beverage Group Invests in Avicanna, a Leading Cannabinoid Biopharmaceutical Platform, Advancing Its Transformation Into Cannabinoid Healthcare (opens original article in a new tab)

Splash Beverage Group invested CDN$300,000 in Avicanna, a cannabinoid biopharmaceutical company, as part of its strategy to transition into a cannabinoid healthcare platform.

• Splash Beverage Group invested CDN$300,000 in Avicanna, a cannabinoid biopharmaceutical company.
• The investment aligns with Splash's transformation into a cannabinoid healthcare platform.
• Avicanna has clinical-stage pharmaceutical assets and operates within Canada's regulated medical cannabis system.